Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Rocky Mountain High Brands, Inc. (RMHB) Message Board

The senator most responsible for legalizing hemp i

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 75350
(Total Views: 1360)
Posted On: 09/18/2019 10:14:41 AM
Posted By: dadon_111
The senator most responsible for legalizing hemp is now trying to use a legislative finance maneuver to speed up federal rules on putting hemp extracts in food and beverages.

Senate Majority Leader Mitch McConnell, a Republican from Kentucky, introduced new language that would require the U.S. Food and Drug Administration (FDA) to issue an “enforcement discretion policy and appropriate regulatory activities” on the sale of hemp-derived CBD products.

FDA’s stance that it is illegal for CBD to be recognized as an ingredient for food, beverages or dietary supplements for interstate commerce continues is a “primary policy challenge” facing businesses in the hemp and CBD industries, the U.S Hemp Roundtable, an industry advocacy group, said in a Tuesday advisory.

The U.S. Senate Appropriations Subcommittee on Agriculture was set to review McConnell’s report Tuesday while the full Senate Appropriations Committee plans to review the language Thursday before it is sent to the Senate floor.

The maneuver would require FDA to:

Provide Congress with a report outlining efforts to develop an enforcement discretion policy on hemp-derived CBD. A process for which CBD meets the definition of hemp will be evaluated for use in products within 90 days.
Issue a formal enforcement discretion policy on products containing hemp-derived CBD within 120 days.
Keep the enforcement discretion policy in effect until the agency has implemented its final regulatory process.
Ensure that CBD manufacturers will be able to share safety data through existing FDA notification procedures to be fully compliant with federal law and policy.

Rock on RMHB
Dadon_111


(14)
(0)




Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us